Home/Filings/4/0001217747-12-000016
4//SEC Filing

DEVINE THOMAS P 4

Accession 0001217747-12-000016

CIK 0001026650other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 5:36 PM ET

Size

19.8 KB

Accession

0001217747-12-000016

Insider Transaction Report

Form 4
Period: 2012-03-05
DEVINE THOMAS P
Exec V.P. & Chief Dev Officer
Transactions
  • Tax Payment

    Common Stock, $.01 par value

    2012-03-05$6.08/sh1,421$8,64050,214 total
Holdings
  • Option (Right to Buy)

    Exercise: $6.46Exp: 2018-03-02Common Stock, $.01 par value (31,553 underlying)
    31,553
  • Option (Right to Buy)

    Exercise: $6.05Exp: 2017-02-26Common Stock, $.01 par value (28,547 underlying)
    28,547
  • Option (Right to Buy)

    Exercise: $4.60Exp: 2016-03-02Common Stock, $.01 par value (50,000 underlying)
    50,000
  • Option (Right to Buy)

    Exercise: $12.00From: 2009-02-28Exp: 2015-02-28Common Stock, $.01 par value (7,500 underlying)
    7,500
  • Option (Right to Buy)

    Exercise: $12.00Exp: 2018-02-28Common Stock, $.01 par value (25,000 underlying)
    25,000
  • Option (Right to Buy)

    Exercise: $7.41Exp: 2014-02-23Common Stock, $.01 par value (20,000 underlying)
    20,000
  • Option (Right to Buy)

    Exercise: $6.49Exp: 2019-02-28Common Stock, $.01 par value (31,580 underlying)
    31,580
  • Option (Right to Buy)

    Exercise: $4.21Exp: 2012-10-22Common Stock, $.01 par value (17,375 underlying)
    17,375
  • Option (Right to Buy)

    Exercise: $14.70Exp: 2013-02-10Common Stock, $.01 par value (20,000 underlying)
    20,000
  • Option (Right to Buy)

    Exercise: $6.29Exp: 2013-04-22Common Stock, $.01 par value (43,688 underlying)
    43,688
  • Option (Right to Buy)

    Exercise: $22.09Exp: 2014-02-09Common Stock, $.01 par value (27,000 underlying)
    27,000
Footnotes (3)
  • [F1]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable three years prior to expiration.
  • [F2]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable six years prior to expiration.
  • [F3]25% of the total options granted became exercisable one year after date of grant. The remaining 75% became exercisable in December 2005.

Issuer

ERESEARCHTECHNOLOGY INC /DE/

CIK 0001026650

Entity typeother

Related Parties

1
  • filerCIK 0001228273

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:36 PM ET
Size
19.8 KB